Workflow
大禹生物(871970) - 2024 Q4 - 年度业绩预告
871970Dayu Biology(871970)2025-01-23 14:15

Financial Performance - The projected net profit for 2024 is estimated to be between -25 million to -21 million CNY, compared to -0.21 million CNY in the same period last year, representing a decline of approximately 1096.29% to 904.88%[5]. - The decline in net profit is primarily attributed to the impact of African swine fever and capacity adjustments, leading to an accelerated exit of small and medium-sized farmers and increased competition in the feedstock market[6]. - The fluctuation in prices of major feed raw materials such as corn and soybean meal has resulted in a decrease in both operating revenue and gross profit compared to the previous year[7]. Operational Challenges - Increased pressure on customer funds in the downstream breeding industry has led to a rise in the provision for bad debts related to accounts receivable during the reporting period[7]. - The company has lowered prices on certain products due to intense competition in the feed and feed additive sector, resulting in increased provisions for inventory write-downs[7]. Risk Disclosure - The financial data presented is preliminary and has not been audited by an accounting firm, with investors advised to pay attention to investment risks[8].